Fayza A Hassan1, Fatma El-Mougy1, Sahar A Sharaf1, Iman Mandour1, Marian F Morgan1, Laila A Selim2, Sawsan A Hassan2, Fadia Salem2, Azza Oraby2, Marian Y Girgis2, Iman G Mahmoud3, Amira El-Badawy3, Ibrahim El-Nekhely4, Nadia Moharam4, Dina A Mehaney1, Mohamed A Elmonem5. 1. Clinical and Chemical Pathology Department, Faculty of Medicine, Cairo University, Cairo, Egypt Inherited Metabolic Disease Unit, Center of Social and Preventive Medicine, Cairo University, Cairo, Egypt. 2. Inherited Metabolic Disease Unit, Center of Social and Preventive Medicine, Cairo University, Cairo, Egypt Pediatrics Department, Faculty of Medicine, Cairo University, Cairo, Egypt. 3. Inherited Metabolic Disease Unit, Center of Social and Preventive Medicine, Cairo University, Cairo, Egypt. 4. Ministry of Health & Population, Cairo, Egypt. 5. Clinical and Chemical Pathology Department, Faculty of Medicine, Cairo University, Cairo, Egypt Inherited Metabolic Disease Unit, Center of Social and Preventive Medicine, Cairo University, Cairo, Egypt mohamed.abdelmonem@kasralainy.edu.eg.
Abstract
OBJECTIVES: To estimate the burden of metabolic disorders detectable by tandem mass spectrometry in Egypt, through a pilot expanded newborn screening programme at Cairo University Children's Hospital in 2008, and examining the results of 3,900 clinically at-risk children, investigated at Cairo University Children's Hospital for the same disorders over the past 7 years using the same technology. METHODS: Dried blood spots of 25,276 healthy newborns from three governorates in Upper, Middle, and Lower Egypt were screened, to give a representative sample of the Egyptian newborn population. Based on the pilot study outcomes and the results of clinically suspected children, we estimated the total birth prevalence of tandem mass spectrometry detectable metabolic disorders, and the relative frequency of several individual disorders. RESULTS: Among the healthy newborns, 13 metabolic disorder cases (five phenylketonuria [1:5,000], two methylmalonic acidemia, and isovaleric acidemia [1:12,500], one each of maple syrup urine disease, propionic acidemia, β-ketothiolase deficiency, and primary carnitine deficiency [1:25,000]) were confirmed, giving a total birth prevalence of 1:1944 live births. Among the clinically suspected children, 235 cases were diagnosed, representing a much wider disease spectrum. CONCLUSIONS: Egypt has one of the highest reported birth prevalence rates for metabolic disorders detectable by tandem mass spectrometry. Early diagnosis and management are crucial for the survival and well-being of affected children. A nationwide NBS programme by tandem mass spectrometry is recommended.
OBJECTIVES: To estimate the burden of metabolic disorders detectable by tandem mass spectrometry in Egypt, through a pilot expanded newborn screening programme at Cairo University Children's Hospital in 2008, and examining the results of 3,900 clinically at-risk children, investigated at Cairo University Children's Hospital for the same disorders over the past 7 years using the same technology. METHODS: Dried blood spots of 25,276 healthy newborns from three governorates in Upper, Middle, and Lower Egypt were screened, to give a representative sample of the Egyptian newborn population. Based on the pilot study outcomes and the results of clinically suspected children, we estimated the total birth prevalence of tandem mass spectrometry detectable metabolic disorders, and the relative frequency of several individual disorders. RESULTS: Among the healthy newborns, 13 metabolic disorder cases (five phenylketonuria [1:5,000], two methylmalonic acidemia, and isovaleric acidemia [1:12,500], one each of maple syrup urine disease, propionic acidemia, β-ketothiolase deficiency, and primary carnitine deficiency [1:25,000]) were confirmed, giving a total birth prevalence of 1:1944 live births. Among the clinically suspected children, 235 cases were diagnosed, representing a much wider disease spectrum. CONCLUSIONS: Egypt has one of the highest reported birth prevalence rates for metabolic disorders detectable by tandem mass spectrometry. Early diagnosis and management are crucial for the survival and well-being of affected children. A nationwide NBS programme by tandem mass spectrometry is recommended.
Authors: Muhammad Wasim; Haq Nawaz Khan; Hina Ayesha; Abdul Tawab; Fazal E Habib; Muhammad Rafique Asi; Mazhar Iqbal; Fazli Rabbi Awan Journal: Int J Dev Disabil Date: 2020-12-21
Authors: Tímea Almási; Lin T Guey; Christine Lukacs; Kata Csetneki; Zoltán Vokó; Tamás Zelei Journal: Orphanet J Rare Dis Date: 2019-04-25 Impact factor: 4.123
Authors: Ting Wang; Jun Ma; Qin Zhang; Ang Gao; Qi Wang; Hong Li; Jingjing Xiang; Benjing Wang Journal: Front Genet Date: 2019-10-29 Impact factor: 4.599